Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients

NCT00330889 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00330889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
February 29, 2004
Completion date
December 31, 2006
Enrollment
32 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid